<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000349442"><TermName>ribonucleotide reductase inhibitor</TermName><TermPronunciation>(RY-boh-NOO-klee-oh-tide ree-DUK-tays in-HIH-bih-ter)</TermPronunciation><TermDefinition><DefinitionText>A family of anticancer drugs that interfere with the growth of tumor cells by blocking the formation of deoxyribonucleotides (building blocks of DNA).</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000711392" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ribonucleotide reductase inhibitor&quot;" language="en" id="_3"/><MediaLink ref="CDR0000711393" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inhibidor de la ribonucleótido reductasa&quot;" language="es" id="_4"/><SpanishTermName>inhibidor de la ribonucleótido reductasa</SpanishTermName><SpanishTermDefinition><DefinitionText>Familia de medicamentos contra el cáncer que interfieren el crecimiento de las células tumorales al impedir la formación de desoxirribonucleótidos (elementos fundamentales del ADN).</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-12-23</DateFirstPublished></GlossaryTerm>
